The lack of a national register for inflammatory bowel diseases (IBD) in Italy complicates health care planning and accurate prevalence assessment.
A study in Messina revealed a significantly higher IBD prevalence (419 per 100,000) compared to regional estimates, with a notable seven-fold increase in incidence over 30 years.
Only a fraction of IBD patients received specialized care, which led to differences in treatment approaches that could impact long-term outcomes and monitoring for complications.